Vertex Pharmaceuticals Incorporated closed at $552.15 on August 20, 2026, marking a 4.58% advance over the prior 24 hours. The gain extended a broader upward trend for the biotech company, which has now risen 5.02% over the past seven days.
Over the trailing 30-day period, shares have surged 14.93%, reflecting sustained buying interest in the stock. The company's market capitalization stood at $133.88 billion as of the close.
The moves place Vertex among the notable performers in the pharmaceutical sector over the near-term window. The 30-day climb represents one of the more pronounced advances logged by a large-cap biotech name in recent weeks, based on the available price data.
